Cargando…

Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders

The diagnosis and management of four cases of dermatological disorders, most of which are related to the endocrine disorder of androgen excess, are presented. Combined oral contraceptives (COCs) may be useful when well-tolerated hormonal therapy and/or when contraception is required. A female patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vázquez, Mercedes Gómez, Amayuelas, Ramón Navarra, Lamarca, Marta, Baquedano, Laura, Ruiz, Sebastián Romero, Vilar-Checa, Eduardo, Iniesta, Maria D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2012
Materias:	Clinical Management
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382652/ https://www.ncbi.nlm.nih.gov/pubmed/21895045 http://dx.doi.org/10.2165/1153875-S0-000000000-00000

Ejemplares similares

Ethinylestradiol/Chlormadinone Acetate: Dermatological Benefits
por: Guerra-Tapia, Aurora, et al.
Publicado: (2012)

Chlormadinone acetate is effective for hot flush during androgen deprivation therapy
por: Koike, Hidekazu, et al.
Publicado: (2013)

Clinical utility of chlormadinone acetate (Lutoral™) in frozen‐thawed embryo transfer with hormone replacement
por: Asada, Yoshimasa, et al.
Publicado: (2019)

The effect of chlormadinone acetate on odontogenic differentiation of human dental pulp cells: in vitro study
por: Kim, Se-Min, et al.
Publicado: (2017)

Chlormadinone acetate in progestin‐primed ovarian stimulation does not negatively affect clinical results
por: Shibasaki, Sena, et al.
Publicado: (2023)

Combined oral contraceptives containing chlormadinone acetate and breast cancer: results of a case-control study.
por: Ebeling, K., et al.
Publicado: (1991)

Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
por: Podfigurna, A., et al.
Publicado: (2019)

A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial
por: Jaisamrarn, Unnop, et al.
Publicado: (2018)

The Effects of Chlormadinone Acetate on Lower Urinary Tract Symptoms and Erectile Functions of Patients with Benign Prostatic Hyperplasia: A Prospective Multicenter Clinical Study
por: Fujimoto, Kiyohide, et al.
Publicado: (2013)

Neutrophlic dermatosis (Sweet's syndrome-like) induced by paracetamol
por: Culla, M Teresa Dordal, et al.
Publicado: (2014)

Pharmacokinetics of drospirenone and ethinylestradiol in Caucasian and Japanese women
por: Blode, Hartmut, et al.
Publicado: (2012)

Inhibitory effect of ethinylestradiol on coagulation factors in rats
por: Franco-Murillo, Yanira, et al.
Publicado: (2016)

Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey
por: Davis, Kimberly H., et al.
Publicado: (2017)

Women consuming oral contraceptives containing cyproterone acetate and ethinylestradiol show a higher risk of thyroid cancer than nonusers
por: Lai, Pei-Hsuan, et al.
Publicado: (2023)

A randomized controlled trial evaluating the effect of low-dose chlormadinone in patients with low-risk prostate cancer: PROSAS study
por: Sugimoto, Mikio, et al.
Publicado: (2021)

Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
por: Mathur, Ruchi, et al.
Publicado: (2008)

Manganese‐oxidizing bacteria mediate the degradation of 17α‐ethinylestradiol
por: Sabirova, Julia S., et al.
Publicado: (2008)

Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis
por: Muchova, Lucie, et al.
Publicado: (2015)

Detecting Traces of 17α-Ethinylestradiol in Complex Water Matrices
por: Zagalo, Paulo M, et al.
Publicado: (2020)

Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function
por: Ågren, Ulla M, et al.
Publicado: (2011)

Ethinylestradiol/gestodene: Isolated cortical cerebral venous thrombosis: case report
Publicado: (2021)

Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism
por: Ågren, Ulla M, et al.
Publicado: (2011)

Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials
por: Archer, David F, et al.
Publicado: (2019)

Removal of ecotoxicity of 17α-ethinylestradiol using TAML/peroxide water treatment
por: Mills, Matthew R., et al.
Publicado: (2015)

The Effect of a Synthetic Estrogen, Ethinylestradiol, on the hERG Block by E-4031
por: Tamura, Fumiya, et al.
Publicado: (2021)

Transcriptomic and Physiological Responses of Chlorella pyrenoidosa during Exposure to 17α-Ethinylestradiol
por: Zhang, Yurui, et al.
Publicado: (2022)

Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives
por: Benagiano, Giuseppe, et al.
Publicado: (2009)

Anchoring Ethinylestradiol Induced Gene Expression Changes with Testicular Morphology and Reproductive Function in the Medaka
por: Miller, Hilary D., et al.
Publicado: (2012)

Developmental exposure to Ethinylestradiol affects transgenerationally sexual behavior and neuroendocrine networks in male mice
por: Derouiche, Lyes, et al.
Publicado: (2015)

Risk–Benefit Assessment of Ethinylestradiol Using a Physiologically Based Pharmacokinetic Modeling Approach
por: Ezuruike, Udoamaka, et al.
Publicado: (2018)

17α-Ethinylestradiol (EE2): concentrations in the environment and methods for wastewater treatment – an update
por: Klaic, Marko, et al.
Publicado: (2022)

Labetalol and soluble endoglin aggravate bile acid retention in mice with ethinylestradiol-induced cholestasis
por: Cristina Igreja Sá, Ivone, et al.
Publicado: (2023)

Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen)
por: Bitzer, Johannes, et al.
Publicado: (2015)

Ethinylestradiol and Levonorgestrel as Active Agents in Normal Skin, and Pathological Conditions Induced by UVB Exposure: In Vitro and In Ovo Assessments
por: Coricovac, Dorina, et al.
Publicado: (2018)

Acetic acid, vinegar, and citric acid as washing materials for cuticle removal to improve hatching performance of quail eggs
por: He, Zhaoxiang, et al.
Publicado: (2020)

Adsorption Behaviors of 17α-Ethinylestradiol in Sediment-Water System in Northern Taihu Lake, China
por: Wang, Yonghua, et al.
Publicado: (2014)

Evaluation of Apelin and Insulin Resistance in Patients with PCOS and Therapeutic Effect of Drospirenone-Ethinylestradiol Plus Metformin
por: Sun, Xianchang, et al.
Publicado: (2015)

Suppression of liver Apo E secretion leads to HDL/cholesterol immaturity in rats administered ethinylestradiol
por: Yamaguchi, Kosuke, et al.
Publicado: (2016)

Ethinylestradiol/norgestimate/lisdexamfetamine: Acute macular neuroretinopathy due to augmentation of hypercoagulable state: case report
Publicado: (2022)

Effect and safety of drospirenone and ethinylestradiol tablets (II) for dysmenorrhea: A systematic review and meta-analysis
por: Shi, Jinghua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ite6ij1psd2d9d9huae1cnphno